Trial intelligence / Profile preview

Early NIPPV in Cancer Patients With Hypoxemic Respiratory Failure

NCT02464696Recruiting

Sponsor
University of Texas MD Anderson Cancer Center
Start
Oct 2015
Primary completion
Oct 2026
Countries
1
01

Overview

Randomised, open-label trial (2 arms), sponsored by University of Texas MD Anderson Cancer Center. Primary endpoint: Percent of patients who require intubation or meet criteria for intubation at 28 days. Started Oct 2015; status: recruiting.

Beyond the preview

Go deeper on NCT02464696.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02464696.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call